Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates potential as once monthly treatment for people with haemophilia AGlobeNewsWire • 07/11/22
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASHBusiness Wire • 06/22/22
Johnson & Johnson Or Novo Nordisk: Which Is The Best Big Pharma Near Cap-GainerSeeking Alpha • 06/16/22
Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1GlobeNewsWire • 06/03/22
Novo Nordisk A/S purchases B shares worth DKK 3,402 million from Novo Holdings A/S under the 2022 share repurchase programmeGlobeNewsWire • 05/03/22
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 29 April 2022GlobeNewsWire • 05/02/22
Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022GlobeNewsWire • 04/29/22